Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors

NCT01876511 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor.

NCT NCT01876511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01876511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
August 31, 2019
Enrollment
113 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

msi negative colorectal cancer, msi positive colorectal cancer, msi positive non-colorectal cancers